The Lancet Oncology · 2019 · 169 citations · 23 references
MedicineOncologyPediatricsMedical OncologyOncology PharmacotherapyPediatric OncologyPediatric LymphomasPharmacokinetics In Children With CancerAtezolizumab TherapyHodgkin Lymphoma TherapyNon-hodgkin Lymphoma TherapyNon-hodgkin Lymphoma TreatmentPediatric Oncology PharmacologyYoung Adulthood
23
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp et al. · The Lancet · 2016 · 4.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Revised Response Criteria for Malignant Lymphoma
Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Peter Schmid, Sylvia Adams, Hope S. Rugo et al. · New England Journal of Medicine · 2018 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17